Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Pharmaceutical Investing
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 Medical Device Investing
CABTREO Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Pharmaceutical Investing
Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203 Pharmaceutical Investing
CORRECTION BY SOURCE: Solta Medical's Thermage FLX and TR-4 Return Pad Receive Registration Certifications in China Pharmaceutical Investing
Solta Medical's Thermage FLX and TR-4 Return Pad Receive Registration Certifications in China Pharmaceutical Investing
